Panagora Asset Management’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-21,436
| Closed | -$1.82M | – | 3127 |
|
|
2020
Q3 | $1.82M | Sell |
21,436
-11,112
| -34% | -$562K | 0.01% | 688 |
|
|
2020
Q2 | $1.15M | Sell |
32,548
-257,450
| -89% | -$7.53M | 0.01% | 877 |
|
|
2020
Q1 | $3.91M | Sell |
289,998
-1,003,341
| -78% | -$16.9M | 0.03% | 406 |
|
|
2019
Q4 | $27.4M | Buy |
1,293,339
+109,349
| +9% | +$1.93M | 0.12% | 178 |
|
|
2019
Q3 | $15.7M | Buy |
1,183,990
+601
| +0.1% | +$8.84K | 0.07% | 253 |
|
|
2019
Q2 | $16.4M | Buy |
1,183,389
+559,594
| +90% | +$8.42M | 0.07% | 255 |
|
|
2019
Q1 | $12M | Buy |
623,795
+6,210
| +1% | +$100K | 0.05% | 320 |
|
|
2018
Q4 | $8.81M | Sell |
617,585
-43,116
| -7% | -$856K | 0.04% | 339 |
|
|
2018
Q3 | $13.8M | Buy |
660,701
+8,757
| +1% | +$207K | 0.05% | 297 |
|
|
2018
Q2 | $15.4M | Buy |
651,944
+49,205
| +8% | +$989K | 0.06% | 262 |
|
|
2018
Q1 | $8.81M | Sell |
602,739
-47,808
| -7% | -$781K | 0.03% | 385 |
|
|
2017
Q4 | $10.5M | Buy |
650,547
+946
| +0.1% | +$11.2K | 0.04% | 380 |
|
|
2017
Q3 | $9.08M | Buy |
649,601
+5,964
| +0.9% | +$59.4K | 0.04% | 424 |
|
|
2017
Q2 | $5.68M | Buy |
643,637
+268,412
| +72% | +$1.88M | 0.02% | 538 |
|
|
2017
Q1 | $2.43M | Buy |
375,225
+57,534
| +18% | +$291K | 0.01% | 807 |
|
|
2016
Q4 | $1.17M | Sell |
317,691
-592,161
| -65% | -$1.75M | 0.01% | 1139 |
|
|
2016
Q3 | $2.96M | Sell |
909,852
-70,592
| -7% | -$197K | 0.01% | 737 |
|
|
2016
Q2 | $2.27M | Buy |
980,444
+105,690
| +12% | +$353K | 0.01% | 821 |
|
|
2016
Q1 | $2.19M | Buy |
874,754
+233,852
| +36% | +$526K | 0.01% | 849 |
|
|
2015
Q4 | $1.97M | Buy |
640,902
+202,128
| +46% | +$564K | 0.01% | 827 |
|
|
2015
Q3 | $755K | Buy |
438,774
+209,638
| +91% | +$535K | ﹤0.01% | 1158 |
|
|
2015
Q2 | $930K | Buy |
229,136
+48,667
| +27% | +$199K | ﹤0.01% | 1131 |
|
|
2015
Q1 | $691K | Sell |
180,469
-379,991
| -68% | -$1.65M | ﹤0.01% | 1201 |
|
|
2014
Q4 | $2.69M | Buy |
560,460
+10,566
| +2% | +$41.8K | 0.01% | 646 |
|
|
2014
Q3 | $2.05M | Buy |
549,894
+19,154
| +4% | +$64.8K | 0.01% | 740 |
|
|
2014
Q2 | $1.94M | Buy |
530,740
+72,324
| +16% | +$266K | 0.01% | 831 |
|
|
2014
Q1 | $1.93M | Sell |
458,416
-2,165
| -0.5% | -$10.7K | 0.01% | 898 |
|
|
2013
Q4 | $2.12M | Buy |
460,581
+5,629
| +1% | +$25.1K | 0.01% | 842 |
|
|
2013
Q3 | $2.82M | Sell |
454,952
-31,908
| -7% | -$184K | 0.01% | 692 |
|
|
2013
Q2 | $2.65M | Buy |
+486,860
| New | +$1.6M | 0.01% | 681 |
|
Panagora Asset Management's IMMU Position: Q4 2020 in Review
Panagora Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 21,436 shares — an estimated $1.82M sold.
Panagora Asset Management first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $27.4M in Q4 2019. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Panagora Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Panagora Asset Management sold 21,436 Immunomedics Inc shares in Q4 2020, an estimated $1.82M.
- Panagora Asset Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Panagora Asset Management's Immunomedics Inc position peaked at $27.4M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Panagora Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.